DOD, Orthotics and Prosthetics Outcomes Clinical Trial Award
The summary for the DOD, Orthotics and Prosthetics Outcomes Clinical Trial Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DOD, Orthotics and Prosthetics Outcomes Clinical Trial Award: The FY23 OPORP CTA is intended to support the rapid implementation of clinical trials with the potential to have a significant impact on improving the health and well-being of Service Members and military beneficiaries, Veterans, and other individuals with limb loss and/or limb impairment. This award mechanism supports clinical trials that evaluate orthoses and/or prostheses using patient-centric outcomes for the purpose of generating clinically useful evidence to enhance and optimize patient outcomes. Proposed projects may range from small proof-of-concept trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials in relevant patient populations. Alternate research designs (e.g., pragmatic and practice-based evidence trials) that provide evidence for adoption of tested orthotic and/or prosthetic devices in real-world clinical practice and inform clinical or policy decisions are particularly encouraged. The FY23 OPORP is also interested in multidisciplinary projects that address strategies to mitigate secondary injuries. Studies proposing or evaluating rehabilitation strategies must indicate how the rehabilitation may improve the orthotic or prosthetic device outcome when compared to standard of care.Applications involving multidisciplinary collaboration among academia, industry, patient advocacy, the military Services, the U.S. Department of Veterans Affairs (VA), and/or other federal government agencies are encouraged but not required.The FY23 OPORP CTA offers funding for two Research Levels (Refer to Section II.D.5, Funding Restrictions). Only one Research Level category may be chosen per application, and the choice of application category is at the discretion of the applicant. The following are generalized descriptions of the scope of research appropriate for each Research Level:• Research Level 1 supports pilot and early-stage clinical trials that are exploratory and involve limited human exposure (e.g., small sample size), with the potential to make significant advancements toward clinical translation. Preliminary data, published or unpublished, are required.• Research Level 2 supports large clinical trials that have the potential to make significant advancement toward clinical translation. Proposed projects may include large-scale trials that, if successful, will produce high-quality outcomes with robust, statistically relevant participant numbers to provide strong, definitive support for evidence-based practice and/or have the potential to drive changes in clinical practice. Pragmatic clinical studies, randomized controlled trials, and comparative effectiveness studies are welcome and encouraged. Published preliminary data relevant to the proposed clinical trial are required. Unpublished preliminary data may be included to further support the study rationale.Preclinical studies using animals are not supported by this program announcement.
Federal Grant Title: | DOD, Orthotics and Prosthetics Outcomes Clinical Trial Award |
Federal Agency Name: | Dept of the Army USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | HT9425-23-OPORP-CTA |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | July 12th, 2023 |
Original Application Deadline: | July 12th, 2023 |
Posted Date: | April 27th, 2023 |
Creation Date: | April 27th, 2023 |
Archive Date: | August 11th, 2023 |
Total Program Funding: | $8,800,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 4 |
Cost Sharing or Matching: | No |
Last Updated: | April 27th, 2023 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DoD Prostate Cancer, Idea Development Award
- • DoD Prostate Cancer, Exploration - Hypothesis Development Award
- • DoD Prostate Cancer, Early Investigator Research Award
- • DoD Prostate Cancer, Physician Research Award
- • DoD Peer Reviewed Cancer, Idea Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • DoD Prostate Cancer, Idea Development Award
- • DoD Prostate Cancer, Exploration - Hypothesis Development Award
- • DoD Prostate Cancer, Early Investigator Research Award